An Introduction to Drug Design (Record no. 41020)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02097 a2200205 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 160114b xxu||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 978-81-224-0943-7 |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 615 |
100 ## - MAIN ENTRY--PERSONAL NAME | |
Personal name | Pandeya, S N |
9 (RLIN) | 20375 |
245 ## - TITLE STATEMENT | |
Title | An Introduction to Drug Design |
Statement of responsibility, etc | D. J. Rimmock and S N Pandeya, |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Name of publisher, distributor, etc | New age International (P) Limited Publisher |
Place of publication, distribution, etc | New Delhi |
Date of publication, distribution, etc | 1997 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 214 p. |
Other physical details | Paper |
505 ## - FORMATTED CONTENTS NOTE | |
Formatted contents note | Section I<br/><br/>Development of New Drugs<br/><br/><br/>Section II<br/><br/>Prodrugs and Soft Drugs<br/><br/><br/>Section III<br/><br/>Chemical Parameters in Drug Design<br/><br/><br/>Section IV<br/><br/>Physicochemical Parameters in Drug Design<br/><br/><br/>Section V<br/><br/>Design of Enzyme Inhibitors<br/><br/><br/>Section VI<br/><br/>Drug Metabolism<br/><br/><br/>Section VII<br/><br/>Molecular Modelling Using Computers<br/><br/><br/>Section VIII<br/><br/>Structure-Based Drug Design. |
520 ## - SUMMARY, ETC. | |
Summary, etc | The book entitled, An Introduction to Drug Design aims to optimize the discovery of drugs at a low cost and on occasions to change their pharmacokinetic and pharmacodyanamic properties. The introductory chapter which forms the basis of drug discovery is followed by the present-day thinking regarding the best approaches to drug discovery are considered. Similarly, there have been major advances in the employment of computers in structure-activity analysis, and a discussion of the state of the art in this area is also included.<br/><br/>The chapter on QSAR highlights the role of physico-chemical parameters in predicting the future course of drug discovery with rational drug design. The role of enzymes in drug action is well established, and a chapter on design of enzyme inhibitors is well documented. In addition, the increased understanding of the design and utilisation of prodrugs has led to a discussion of the relevant issues in this text.<br/><br/>Thus the book will fill the need of a text for designing new drugs and the principles of new drug discovery. |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Pharmaceutical management |
9 (RLIN) | 20376 |
Topical term or geographic name as entry element | Drug Design |
9 (RLIN) | 20377 |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Dimmock, J R |
9 (RLIN) | 20378 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | Dewey Decimal Classification |
Item type | Book |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection code | Home library | Current library | Shelving location | Date acquired | Source of acquisition | Cost, normal purchase price | Total Checkouts | Full call number | Barcode | Date last seen | Cost, replacement price | Price effective from |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dewey Decimal Classification | Main Library | Main Library | ON SHELF | 14/01/2016 | Bombay Books / IN1005/ 14-January-2015 | 159.20 | 615/ Pan/Dim/ 30498 | 11130498 | 07/06/2022 | 199.00 | 14/01/2016 |